Unknown

Dataset Information

American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults.


ABSTRACT:

Background

Older adults with acute myeloid leukemia (AML) represent a vulnerable population in whom disease-based and clinical risk factors, patient goals, prognosis, and practitioner- and patient-perceived treatment risks and benefits influence treatment recommendations.

Objective

These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in their decisions about management of AML in older adults.

Methods

ASH formed a multidisciplinary guideline panel that included specialists in myeloid leukemia, geriatric oncology, patient-reported outcomes and decision-making, frailty, epidemiology, and methodology, as well as patients. The McMaster Grading of Recommendations Assessm

SUBMITTER: Sekeres MA 

PROVIDER: S-EPMC7422124 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature